Supply Chain

The FDA has authorized Abbott's BinaxNOW COVID-19 test for at-home use. The test was previously authorized for use by a trained professional only. 

In September, California passed a law that will require all hospitals in the state to maintain three-month stockpiles of new, unexpired and unused personal protective equipment starting in April. The law was created in response to widespread shortages of PPE…

People with rare diseases who often had to wear personal protective gear before the COVID-19 pandemic are now struggling to get it due to the pandemic, according to a survey by the National Organization for Rare Disorders.

The FDA granted emergency approval Dec. 15 for the first fully at-home COVID-19 diagnostic test, which doesn't need a prescription and doesn't need to be sent to a lab. 

As we approach the end of the year, many health systems will likely be looking for opportunities for any additional cost savings after facing financial headwinds throughout 2020.

Ten hospitals and health systems posted job listings for supply chain expertise in the last week:

To be better prepared for future crises like the COVID-19 pandemic, the U.S. shouldn't rely on replenishing its Strategic National Stockpile, but rather the stockpile should evolve to create better visibility into the supply chain, health experts told Bloomberg. 

The FDA authorized Dec. 9 the first at-home COVID-19 test that doesn't require a prescription.

Federal authorities seized more than 100,000 fake N95 masks worth more than $600,000 from a warehouse in Texas, according to a statement from U.S. Immigration and Customs Enforcement. 

Industries as complex as healthcare - where multiple stakeholders impact strategy, day-to-day decision making and management - require technology to implement effective collaboration and drive operations in a cost-effective way. Spend savings is of paramount importance across most industries, especially…